Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
Technology
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/8a/fe/66/8afe6698-90f6-850f-8c57-0e6b11e65b38/mza_11611672527054683984.jpeg/600x600bb.jpg
Beyond the Chart: Exploring the AI Frontier for Oncology
Matthew Ko
7 episodes
1 week ago
Beyond the Chart examines the current state of cancer care delivery and AI technology's role in oncology centers today and in a promising future. Each episode features detailed conversations with oncology leaders and clinicians, health tech innovators, and entrepreneurs driving change at the intersection of AI and oncology. Learn how intelligent tools transform clinical workflows, decision-making, and the patient experience.  Tune in for out-of-the-box thinking, real-world outcomes, and a front-row seat to the future of oncology.
Show more...
Health & Fitness
RSS
All content for Beyond the Chart: Exploring the AI Frontier for Oncology is the property of Matthew Ko and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Beyond the Chart examines the current state of cancer care delivery and AI technology's role in oncology centers today and in a promising future. Each episode features detailed conversations with oncology leaders and clinicians, health tech innovators, and entrepreneurs driving change at the intersection of AI and oncology. Learn how intelligent tools transform clinical workflows, decision-making, and the patient experience.  Tune in for out-of-the-box thinking, real-world outcomes, and a front-row seat to the future of oncology.
Show more...
Health & Fitness
https://megaphone.imgix.net/podcasts/3b1549aa-9edf-11f0-b985-2307e51be341/image/c1d9134fa6e13c2e1e00ddeb0114f1c2.png?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress
Ep. 5: Grit, Trust, and the Human Side of AI: Leading Community Oncology Forward | Kathy Oubre, CEO of Pontchartrain Cancer Center
Beyond the Chart: Exploring the AI Frontier for Oncology
41 minutes
1 month ago
Ep. 5: Grit, Trust, and the Human Side of AI: Leading Community Oncology Forward | Kathy Oubre, CEO of Pontchartrain Cancer Center
Technology can actually make oncology care feel more human by restoring trust and presence between doctors and patients. In this episode, Kathy Oubre, CEO of Pontchartrain Cancer Center, shares how community oncology faces unique challenges compared to academic centers, including competition with 340B hospitals and the need for resilience and innovation. She highlights how adopting ambient AI enhanced patient care by deepening relationships and restoring trust eroded by EMRs, while also being quickly embraced by patients through transparency and clear communication. Kathy discusses both the promise of AI in areas like precision medicine, imaging, and prior authorizations, and the risks around data safety and over-reliance on automation. She closes by reframing oncology as a privilege, centered on compassion and presence during life’s most difficult moments. Tune in and learn how AI, when thoughtfully applied, can innovate cancer care while preserving its most human core Resources: Follow and connect with Kathy Oubre on LinkedIn. Follow Pontchartrain Cancer Center on LinkedIn and explore their website.
Beyond the Chart: Exploring the AI Frontier for Oncology
Beyond the Chart examines the current state of cancer care delivery and AI technology's role in oncology centers today and in a promising future. Each episode features detailed conversations with oncology leaders and clinicians, health tech innovators, and entrepreneurs driving change at the intersection of AI and oncology. Learn how intelligent tools transform clinical workflows, decision-making, and the patient experience.  Tune in for out-of-the-box thinking, real-world outcomes, and a front-row seat to the future of oncology.